journal article·2015-09Open access

Porphyrin-vancomycin: A highly promising conjugate for the identification and photodynamic inactivation of antibiotic resistant Gram-positive pathogens

Le Zhai, Ke-Wu Yang

Dyes and Pigments· Volume 120

Abstract

The emergence of drug-resistant pathogens is a global public health problem. With the increasing antibiotic resistance of bacteria, there is an obvious need for the development for alternative therapeutics and materials that can effectively control this situation. In this work, a new conjugate, 5,10,15,20-tetrakis ( para -aminophenyl) porphyrin-vancomycin was successfully explored for the identification and photoinactivation of antibiotic resistant Gram-positive pathogens. The minimum inhibitory concentration assay and photodynamic inactivation evaluation results revealed that the conjugate can effective inhibit the growth of 6 tested pathogenic strains under white light . The interaction intensity of the conjugate with Gram-positive and Gram-negative bacterial cells was evaluated by surface plasmon resonance , and the results showed that its activity toward Staphylococcus aureus was 14-fold larger than its activity toward Escherichia coli at 20 mM, indicating the conjugate selectively gathers in Gram-positive cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Ocular Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. The structure and mode of action of glycopeptide antibiotics of the vancomycin group10.1146/annurev.mi.38.100184.002011 ↗
2. Structure, biochemistry and mechanism of action of glycopeptide antibiotics10.1007/BF01967563 ↗
3. Glycopeptide and lipoglycopeptide antibiotics10.1021/cr030103a ↗
4. Vancomycin resistance: decoding the molecular logic10.1126/science.8392747 ↗
5. Genetics and mechanisms of glycopeptide resistance in enterococci10.1128/AAC.37.8.1563 ↗
6. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci10.1046/j.1365-2958.1996.00617.x ↗
7. Vancomycin resistance in enterococci: reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis10.1016/S1074-5521(00)00116-2 ↗
8. Multivalent vancomycins and related antibiotics against infectious diseases10.2174/1381612054864975 ↗
9. Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues10.1002/chem.201102195 ↗
10. An analysis of the origins of a cooperative binding energy of dimerization10.1126/science.280.5364.711 ↗
11. The structural biology of molecular recognition by vancomycin10.1146/annurev.biophys.29.1.265 ↗
12. How does photodynamic therapy work?10.1111/j.1751-1097.1992.tb04222.x ↗
13. Photodynamic therapy for cancer10.1038/nrc1071 ↗
14. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
15. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
16. Antibacterial photodynamic therapy in dermatology10.1039/b407622b ↗
17. Photodynamic therapy targeted to pathogens10.1177/039463200401700304 ↗
18. Multifunctional divalent vancomycin: the fluorescent imaging and photodynamic antimicrobial properties for drug resistant bacteria10.1039/C0CC04434B ↗
19. Photoactive hybrid nanomaterial for targeting, labeling, and killing antibiotic-resistant bacteria10.1002/anie.200902837 ↗
20. Conjugated polymer/porphyrin complexes for efficient energy transfer and improving light-activated antibacterial activity10.1021/ja904492x ↗
21. Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer10.1021/la7021424 ↗
22. Enzyme responsive luminescent ruthenium(II) cephalosporin probe for intracellular imaging and photoinactivation of antibiotics resistant bacteria10.1039/C1CC16165B ↗
23. Porphyrin FRET acceptors for apoptosis induction and monitoring10.1021/ja2083569 ↗
24. Photodynamic inactivation of Candida albicans sensitized by tri- and tetra-cationic porphyrin derivatives10.1016/j.ejmech.2008.07.026 ↗
25. Electrochemical polymerization of amino-, pyrrole-, and hydroxy-substituted tetraphenylporphyrins10.1021/ic00254a011 ↗
26. Noncovalent functionalization of single-walled carbon nanotube by porphyrin: dispersion of carbon nanotubes in water and formation of self-assembly donor-acceptor nanoensemble10.1080/01932690903107133 ↗
27. Wayne · 2009
28. Novel fluorescent cephalosporins: synthesis, antimicrobial activity and photodynamic inactivation of antibiotic resistant bacteria10.1016/j.ejmech.2012.11.019 ↗
29. Photoinactivation of vancomycin-resistant enterococci and bacillus subtilis by a novel norvancomycin-rhodamine B conjugate10.1039/c2nj40906b ↗
30. Two distinct binding affinities of poliovirus for its cellular receptor10.1074/jbc.M002146200 ↗
31. Distinct cellular receptor interactions in poliovirus and rhinoviruses10.1093/emboj/19.6.1207 ↗
32. Interaction between viruses and monoclonal antibodies studied by surface plasmon resonance10.1016/0165-2478(92)90011-C ↗
33. Real-time analysis of antibody interactions with whole enveloped human cytomegalovirus using surface plasmon resonance10.1016/j.ab.2010.12.017 ↗
34. A g-quadruplex ligand with 10000-fold selectivity over duplex DNA10.1021/ja065591t ↗
35. Porphyrin derivatives for telomere binding and telomerase inhibition10.1002/cbic.200400113 ↗
36. Substitution effects on the UV–vis and 1H NMR spectra of the dications of meso and/or β substituted porphyrins with trifluoroacetic acid: electron-deficient porphyrins compared to the electron-rich ones10.1016/j.inoche.2011.08.019 ↗
37. UV-visible, fluorescence and EPR properties of porphyrins and metalloporphyrins10.1016/j.dyepig.2007.04.007 ↗